Package 31722-089-30

Brand: darunavir

Generic: darunavir
NDC Package

Package Facts

Identity

Package NDC 31722-089-30
Digits Only 3172208930
Product NDC 31722-089
Product ID 31722-089_30b10990-92c4-531b-e063-6294a90a7a27
Description

30 TABLET, FILM COATED in 1 BOTTLE (31722-089-30)

Marketing

Marketing Status
Marketed Since 2025-01-21
Brand darunavir
Generic darunavir
Sample Package No

Linked Drug Pages (1)

Darunavir ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "30b10990-92c4-531b-e063-6294a90a7a27", "openfda": {"nui": ["N0000000246", "N0000175889", "N0000190114", "N0000182137"], "unii": ["YO603Y8113"], "rxcui": ["670026", "1359269"], "spl_set_id": ["49606d5e-f45f-45eb-9ab8-15aa6a233875"], "pharm_class_epc": ["Protease Inhibitor [EPC]"], "pharm_class_moa": ["HIV Protease Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (31722-089-30)", "package_ndc": "31722-089-30", "marketing_start_date": "20250121"}], "brand_name": "Darunavir", "product_id": "31722-089_30b10990-92c4-531b-e063-6294a90a7a27", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "HIV Protease Inhibitors [MoA]", "Protease Inhibitor [EPC]"], "product_ndc": "31722-089", "generic_name": "Darunavir", "labeler_name": "Camber Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Darunavir", "active_ingredients": [{"name": "DARUNAVIR", "strength": "800 mg/1"}], "application_number": "ANDA216168", "marketing_category": "ANDA", "marketing_start_date": "20250121", "listing_expiration_date": "20261231"}